Artiva Biotherapeutics, Common Stock Current Ratio
| ARTV Stock | 10.24 0.80 7.25% |
Artiva Biotherapeutics, Common fundamentals help investors to digest information that contributes to Artiva Biotherapeutics,'s financial success or failures. It also enables traders to predict the movement of Artiva Stock. The fundamental analysis module provides a way to measure Artiva Biotherapeutics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Artiva Biotherapeutics, stock.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 6.53 | 4.71 |
Artiva | Current Ratio |
Artiva Biotherapeutics, Common Company Current Ratio Analysis
Artiva Biotherapeutics,'s Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Artiva Biotherapeutics, Current Ratio | 4.71 |
Most of Artiva Biotherapeutics,'s fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Artiva Biotherapeutics, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Artiva Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Artiva Biotherapeutics, is extremely important. It helps to project a fair market value of Artiva Stock properly, considering its historical fundamentals such as Current Ratio. Since Artiva Biotherapeutics,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Artiva Biotherapeutics,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Artiva Biotherapeutics,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Artiva Current Ratio Historical Pattern
Today, most investors in Artiva Biotherapeutics, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Artiva Biotherapeutics,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Artiva Biotherapeutics, current ratio as a starting point in their analysis.
Artiva Biotherapeutics, Current Ratio |
| Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
Artiva Price To Sales Ratio
Price To Sales Ratio |
|
Artiva Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Artiva Biotherapeutics,'s direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Artiva Biotherapeutics, could also be used in its relative valuation, which is a method of valuing Artiva Biotherapeutics, by comparing valuation metrics of similar companies.Artiva Biotherapeutics, is currently under evaluation in current ratio category among its peers.
Artiva Fundamentals
| Return On Equity | -0.44 | ||||
| Operating Margin | (23.45) % | ||||
| Current Valuation | 136.49 M | ||||
| Shares Outstanding | 24.29 M | ||||
| Shares Owned By Insiders | 20.64 % | ||||
| Shares Owned By Institutions | 89.07 % | ||||
| Number Of Shares Shorted | 1.03 M | ||||
| Price To Book | 1.33 X | ||||
| Price To Sales | 103.10 X | ||||
| Revenue | 33.49 M | ||||
| EBITDA | (28.41 M) | ||||
| Net Income | (28.72 M) | ||||
| Total Debt | 16.91 M | ||||
| Book Value Per Share | 8.28 X | ||||
| Cash Flow From Operations | (47.43 M) | ||||
| Short Ratio | 20.47 X | ||||
| Earnings Per Share | (2.48) X | ||||
| Target Price | 21.25 | ||||
| Number Of Employees | 82 | ||||
| Market Capitalization | 268.15 M | ||||
| Total Asset | 105.11 M | ||||
| Retained Earnings | (181.31 M) | ||||
| Working Capital | 67.59 M | ||||
| Net Asset | 105.11 M |
About Artiva Biotherapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Artiva Biotherapeutics, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Artiva Biotherapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Artiva Biotherapeutics, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.